Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Infection, inflammation, height, and longevity
2005 Standout
Jinx , an MCMV susceptibility phenotype caused by disruption of Unc13d : a mouse model of type 3 familial hemophagocytic lymphohistiocytosis
2007 StandoutNobel
Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4+ Memory T Cells by Releasing Antigenic Exosomes
2009
Chimerism of the Transplanted Heart
2002 Standout
Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice
2001
Antibiotic Treatment ofChlamydia pneumoniaeafter Acute Coronary Syndrome
2005 Standout
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
Chronic Rejection in Kidney Transplants
1999
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
ATP-sensitive potassium channels mediate survival during infection in mammals and insects
2007 StandoutNobel
Infectious agents and atherosclerotic vascular disease
1996
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Membrane vesicles as conveyors of immune responses
2009 Standout
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels
2000
Cytomegalovirus Infection Following Liver Transplantation: Review of the Literature
1996
Regulation of Coronary Blood Flow During Exercise
2008
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Cardiovascular Toxicities of Immunosuppressive Agents
2002
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Hemodynamic Shear Stress and Its Role in Atherosclerosis
1999 Standout
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2008
Improving Outcomes for Solid-Organ Transplant Recipients At Risk from Cytomegalovirus Infection: Late-Onset Disease and Indirect Consequences
2008
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
Chronic renal transplant loss
1995
Dendritic Cells
1999
Atherosclerosis — An Inflammatory Disease
1999 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 Standout
l-Nucleoside enantiomers as antivirals drugs: A mini-review
2006
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors
1997
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Dilation of the aortic root in children infected with human immunodeficiency virus type 1: The Prospective P2C2 HIV Multicenter Study
2001
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 StandoutNature
Infection in Organ-Transplant Recipients
1998 Standout
Impact of Cytomegalovirus Infection on Organ Transplant Recipients
1990
The contribution of inducible nitric oxide and cytomegalovirus to the stability of complex carotid plaque
1999
Use of potentially infected donor hearts for cardiac transplantation
1990
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
2000 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction
2000 Standout
Endothelial Dysfunction and Cytomegalovirus Replication in Pediatric Heart Transplantation
2008
Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.
1996
Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.
1991
Herpesviruses in Atherosclerosis and Thrombosis
1998
Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis.
1994
Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.
1992
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Cohort Study of Cytomegalovirus Infection as a Risk Factor for Carotid Intimal-Medial Thickening, a Measure of Subclinical Atherosclerosis
1996
Interferon γ Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels
1998
Pertussis toxin-sensitive G protein mediates coronary microvascular control during autoregulation and ischemia in canine heart.
1994
Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes.
1991
Oxidized Low Density Lipoproteins in Patients With Transplant-Associated Coronary Artery Disease
1998
Inflammation and Atherosclerosis
2002 Standout
Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.
1997
Human Cytomegalovirus Inhibits Cytokine-Induced Macrophage Differentiation
2004
Impact of Prophylactic Immediate Posttransplant Ganciclovir on Development of Transplant Atherosclerosis
1999
Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.
1991
Cardiac Allograft Vasculopathy
2008
The Indirect Effects of Cytomegalovirus Infection on the Outcome of Organ Transplantation
1989
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
Cardiac Allograft Vasculopathy
1997
Restoration of β-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer
1997 StandoutNobel
Immunobiology of Dendritic Cells
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
2000 Standout
The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus
1996
Intracellular Signaling by the Chemokine Receptor US28 during Human Cytomegalovirus Infection
1998
Prospective Study of Herpes Simplex Virus, Cytomegalovirus, and the Risk of Future Myocardial Infarction and Stroke
1998
GENETIC ANALYSIS OF HOST RESISTANCE: Toll-Like Receptor Signaling and Immunity at Large
2006 StandoutNobel
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Adenosine, the heart, and coronary circulation.
1991
Chlamydial Heat Shock Protein 60 Localizes in Human Atheroma and Regulates Macrophage Tumor Necrosis Factor-α and Matrix Metalloproteinase Expression
1998 Standout
Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure
1995
Cytomegalovirus Infection–Enhanced Cardiac Allograft Vasculopathy Is Abolished by DHPG Prophylaxis in the Rat
1997
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)
2000
Possible Role of Cytomegalovirus in Atherogenesis
1990
Task force 5: Complications
1993
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Inflammatory Exposure and Historical Changes in Human Life-Spans
2004 StandoutScience
Flow-mediated endothelial mechanotransduction
1995 Standout
Cytomegalovirus Antigen Expression, Endothelial Cell Proliferation, and Intimal Thickening in Rat Cardiac Allografts After Cytomegalovirus Infection
1995
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Molecular Bases of the Acute Coronary Syndromes
1995 Standout
Works of Mark T. Grattan being referenced
Role of adenosine in coronary autoregulation
1986
Beta-adrenergic receptor properties of canine myocardium: Effects of chronic myocardial infarction
1986
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
1989
Transmural coronary flow reserve patterns in dogs
1986